Influence of IFNL3 and HLA-DPB1 genotype on postpartum control of hepatitis C virus replication and T-cell recovery

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 38, 2016, Pages 10684-10689

  Honegger, Jonathan R ^a,b   Tedesco, Dana ^c   Kohout, Jennifer A ^a   Prasad, Mona R ^b   Price, Aryn A ^c   Lindquist, Tera ^a   Ohmer, Samantha ^d   Moore Clingenpeel, Melissa ^a   Grakoui, Arash ^c   Walker, Christopher M ^a,b  

^a THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

Hepatitis C virus; HLA DPB1; IFNL3; Pregnancy; T cell

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DPB1 ANTIGEN; INTERFERON; INTERFERON LAMBDA 3; UNCLASSIFIED DRUG; HLA DP ANTIGEN; HLA-DPB1 ANTIGEN; IFIT3 PROTEIN, HUMAN; SIGNAL PEPTIDE;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; PRIORITY JOURNAL; PUERPERIUM; T LYMPHOCYTE; THIRD TRIMESTER PREGNANCY; TREATMENT RESPONSE; VIREMIA; VIRUS LOAD; VIRUS REPLICATION; CHRONIC HEPATITIS C; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; HEPACIVIRUS; IMMUNOLOGY; MOTHER FETUS RELATIONSHIP; PATHOGENICITY; PREGNANCY; SINGLE NUCLEOTIDE POLYMORPHISM; VIROLOGY;

ADULT; FEMALE; GENE EXPRESSION REGULATION; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HLA-DP BETA-CHAINS; HUMANS; IMMUNITY, CELLULAR; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MATERNAL-FETAL RELATIONS; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTPARTUM PERIOD; PREGNANCY; T-LYMPHOCYTES; VIRAL LOAD; VIRUS REPLICATION;

EID: 84988569217     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1602337113     Document Type: Article

References (41)

1. Rehermann B (2009) Hepatitis C virus versus innate and adaptive immune responses: A tale of coevolution and coexistence. J Clin Invest 119(7):1745-1754.
2. Bowen DG, Walker CM (2005) Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 436(7053):946-952.
3. + T cell immunity: HCV evolution, from chimpanzees to man. J Exp Med 201(11):1709-1714.
4. Schulze Zur Wiesch J, et al. (2012) Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence. J Exp Med 209(1):61-75.
5. McGovern BH, et al. (2009) Improving the diagnosis of acute hepatitis C virus infection with expanded viral load criteria. Clin Infect Dis 49(7):1051-1060.
6. Lin HH, Kao JH (2000) Hepatitis C virus load during pregnancy and puerperium. BJOG 107(12):1503-1506.
7. Paternoster DM, et al. (2001) Viral load in HCV RNA-positive pregnant women. Am J Gastroenterol 96(9):2751-2754.
8. Gervais A, et al. (2000) Decrease in serum ALT and increase in serum HCV RNA during pregnancy in women with chronic hepatitis C. J Hepatol 32(2):293-299.
9. Ruiz-Extremera A, et al. (2013) Variation of transaminases, HCV-RNA levels and Th1/Th2 cytokine production during the post-partum period in pregnant women with chronic hepatitis C. PLoS One 8(10):e75613.
10. Honegger JR, et al. (2013) Loss of immune escape mutations during persistent HCV infection in pregnancy enhances replication of vertically transmitted viruses. Nat Med 19(11):1529-1533.
11. Duggal P, et al. (2013) Genome-wide association study of spontaneous resolution of hepatitis C virus infection: Data from multiple cohorts. Ann Intern Med 158(4):235-245.
12. Thomas DL, et al. (2009) Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461(7265):798-801.
13. Ge D, et al. (2009) Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461(7262):399-401.
14. Schmidt J, Thimme R, Neumann-Haefelin C (2011) Host genetics in immune-mediated hepatitis C virus clearance. Biomarkers Med 5(2):155-169.
15. McKiernan SM, et al. (2004) Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source. Hepatology 40(1):108-114.
16. Thio CL, et al. (2002) HLA-Cw∗04 and hepatitis C virus persistence. J Virol 76(10):4792-4797.
17. Kuniholm MH, et al. (2010) Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia. Hepatology 51(5):1514-1522.
18. Hong X, et al. (2005) Human leukocyte antigen class II DQB1∗0301, DRB1∗1101 alleles and spontaneous clearance of hepatitis C virus infection: A meta-analysis. World J Gastroenterol 11(46):7302-7307.
19. Wejstål R, Widell A, Norkrans G (1998) HCV-RNA levels increase during pregnancy in women with chronic hepatitis C. Scand J Infect Dis 30(2):111-113.
20. Thimme R, et al. (2002) Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc Natl Acad Sci USA 99(24):15661-15668.
21. Messina JP, et al. (2015) Global distribution and prevalence of hepatitis C virus genotypes. Hepatology 61(1):77-87.
22. Rauch A, et al. (2010) Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: A genome-wide association study. Gastroenterol 138(4):1338-1345, e1331-e1337.
23. Uccellini L, et al. (2012) HCV RNA levels in a multiethnic cohort of injection drug users: Human genetic, viral and demographic associations. Hepatology 56(1):86-94.
24. Mast EE, et al. (2005) Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J Infect Dis 192(11):1880-1889.
25. Dal Molin G, et al. (2002) Mother-to-infant transmission of hepatitis C virus: Rate of infection and assessment of viral load and IgM anti-HCV as risk factors. J Med Virol 67(2):137-142.
26. Prokunina-Olsson L, et al. (2013) A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet 45(2):164-171.
27. O'Brien TR, et al. (2015) Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance. J Hepatol 63(5):1103-1110.
28. Bes M, et al. (2012) IL28B genetic variation and hepatitis C virus-specific CD4(+) T-cell responses in anti-HCV-positive blood donors. J Viral Hepat 19(12):867-871.
29. Grimm D, Neumann-Haefelin C, Kersting N, Blum HE, Thimme R (2011) IL28B genotype and hepatitis C virus specific T cell response. Zeitschrift für Gastroenterologie 49(01):P4-23.
30. Thomas R, et al. (2012) A novel variant marking HLA-DP expression levels predicts recovery from hepatitis B virus infection. J Virol 86(12):6979-6985.
31. Petersdorf EW, et al. (2015) High HLA-DP Expression and graft-versus-host disease. N Engl J Med 373(7):599-609.
32. Kamatani Y, et al. (2009) A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet 41(5):591-595.
33. Sidney J, et al. (2010) Five HLA-DP molecules frequently expressed in the worldwide human population share a common HLA supertypic binding specificity. J Immunol 184(5):2492-2503.
34. McKiernan SM, et al. (2000) The MHC is a major determinant of viral status, but not fibrotic stage, in individuals infected with hepatitis C. Gastroenterology 118(6):1124-1130.
35. Fitzmaurice K, et al.; Irish HCV Research Consortium; Swiss HIV Cohort Study (2015) Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection. Gut 64(5):813-819.
36. Xu X, et al. (2014) Genetic variants in human leukocyte antigen-DP influence both hepatitis C virus persistence and hepatitis C virus F protein generation in the Chinese Han population. Int J Mol Sci 15(6):9826-9843.
37. Kahan SM, Wherry EJ, Zajac AJ (2015) T cell exhaustion during persistent viral infections. Virology 479-480:180-193.
38. Singh N, Perfect JR (2007) Immune reconstitution syndrome and exacerbation of infections after pregnancy. Clin Infect Dis 45(9):1192-1199.
39. Ticehurst JR, Hamzeh FM, Thomas DL (2007) Factors affecting serum concentrations of hepatitis C virus (HCV) RNA in HCV genotype 1-infected patients with chronic hepatitis. J Clin Microbiol 45(8):2426-2433.
40. Urban TJ, et al. (2010) IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C. Hepatology 52(6):1888-1896.
41. Lanteri MC, et al. (2011) Association between HLA class I and class II alleles and the outcome of West Nile virus infection: An exploratory study. PloS One 6(8):e22948.